Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Hematologic traits and primary biliary cholangitis: a Mendelian randomization study

Abstract

Hematologic abnormalities was observationally associated with the susceptibility of primary biliary cholangitis (PBC). However, the conclusion is still controversial and whether there exists a causal association remains elusive. Here we aimed to explore the causative role of hematological traits in the risk of PBC. We conducted two-sample and multivariable Mendelian randomization analyses based on summary statistics from previous large genome-wide association studies. Totally twelve red blood cell and six white blood cell traits were analyzed. Genetically determined higher hemoglobin level was significantly associated with a reduced risk of PBC (OR: 0.62, 95% CI: 0.47ā€“0.81, P: 5.59Eāˆ’04). Meanwhile, higher hematocrit level was nominally associated with reduced risk of PBC (OR: 0.73, 95% CI: 0.57ā€“0.93, P: 0.01). These results could help better understand the role of hematological traits in the risk of PBC, and provide potential targets for the disease prevention and treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Data availability

Summary statistics of PBC could be downloaded from the GWAS Catalog (https://www.ebi.ac.uk/gwas/home, ID: GCST90061440). Summary statistics of each blood cell trait could be found in the original publication.

References

  1. Lleo A, Wang GQ, Gershwin ME, Hirschfield GM. Primary biliary cholangitis. Lancet. 2020;396:1915ā€“26.

    ArticleĀ  CASĀ  Google ScholarĀ 

  2. Lleo A, Leung PSC, Hirschfield GM, Gershwin EM. The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review. Semin Liver Dis. 2020;40:34ā€“48.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  3. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. Hepatology. 2005;42:1194ā€“202.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  4. Marks PW. Hematologic manifestations of liver disease. Semin Hematol. 2013;50:216ā€“21.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  5. Yoo JJ, Cho EJ, Lee B, Kim SG, Kim YS, Lee YB, et al. Prognostic Value of Biochemical Response Models for Primary Biliary Cholangitis and the Additional Role of the Neutrophil-to-Lymphocyte Ratio. Gut liver. 2018;12:714ā€“21.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  6. Wang LL, Wei TT, Yin JR, Qin BD, Ma N, Tang QQ, et al. Red blood cell distribution width and mean platelet volume are potential prognostic indices for patients with primary biliary cirrhosis. Clin Chem Lab Med. 2017;55:e127ā€“9.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  7. Meng J, Xu H, Liu X, Wu R, Niu J. Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis. Medicine. 2018;97:e13431.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  8. Wang H, Xu H, Wang X, Wu R, Gao X, Jin Q, et al. Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis. Medicine. 2016;95:e3114.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  9. Li C, Liu J, Lin J, Shang H. COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study. Transl Psychiatry. 2022;12:283.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  10. Astle WJ, Elding H, Jiang T, Allen D, Ruklisa D, Mann AL, et al. The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease. Cell. 2016;167:1415ā€“29.e19.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  11. Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, et al. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs. J Hepatol. 2021;75:572ā€“81.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  12. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73ā€“84.

    ArticleĀ  PubMedĀ  Google ScholarĀ 

  13. Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518:197ā€“206.

    ArticleĀ  CASĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  14. Duszynski CC, Avati V, Lapointe AP, Scholkmann F, Dunn JF, Swain MG. Near-Infrared Spectroscopy Reveals Brain Hypoxia and Cerebrovascular Dysregulation in Primary Biliary Cholangitis. Hepatology. 2020;71:1408ā€“20.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  15. Tsuneyama K, Harada K, Kono N, Sasaki M, Saito T, Gershwin ME, et al. Damaged interlobular bile ducts in primary biliary cirrhosis show reduced expression of glutathione-S-transferase-pi and aberrant expression of 4-hydroxynonenal. J Hepatol. 2002;37:176ā€“83.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  16. Lefere S, Van Steenkiste C, Verhelst X, Van Vlierberghe H, Devisscher L, Geerts A. Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease. Cell Mol Life Sci. 2016;73:3419ā€“31.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

  17. Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and Fibrogenesis in Chronic Liver Diseases. Cell Mol Gastroenterol Hepatol. 2015;1:477ā€“88.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  18. Foglia B, Novo E, Protopapa F, Maggiora M, Bocca C, Cannito S, et al. Hypoxia, Hypoxia-Inducible Factors and Liver Fibrosis. Cells 2021;10::1764.

    ArticleĀ  PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  19. Chung CS, Hsu YC, Huang SY, Jeng YM, Chen CH. Primary biliary cirrhosis associated with pernicious anemia. Can Fam Physician. 2010;56:889ā€“91.

    PubMedĀ  PubMed CentralĀ  Google ScholarĀ 

  20. Shiomi S, Kuroki T, Fujimoto S, Yamaoka M, Sakaguchi H, Takeda T, et al. Primary biliary cirrhosis complicated by severe hypoxemia. J Gastroenterol. 1995;30:790ā€“4.

    ArticleĀ  CASĀ  PubMedĀ  Google ScholarĀ 

Download references

Acknowledgements

This research was supported by the funding of the National Key Research and Development Program of China (Grant No. 2021YFC2501200) and the Sichuan Science and Technology Program (Grant No. 2022ZDZX0023 and 2021YJ0415).

Author information

Authors and Affiliations

Authors

Contributions

(1) Research project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) paper: A. Writing of the First Draft, B. Review and Critique. BK: 1A, 1C, 2A, 2B, 3A; C.L.: 1B, 2C, 3B; H.S.: 1B, 2C, 3B.

Corresponding authors

Correspondence to Chunyu Li or Huifang Shang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisherā€™s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ke, B., Li, C. & Shang, H. Hematologic traits and primary biliary cholangitis: a Mendelian randomization study. J Hum Genet 68, 559ā€“563 (2023). https://doi.org/10.1038/s10038-023-01146-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-023-01146-0

Search

Quick links